NCT01327976 - The Safety and Efficacy of vBloc Therapy Delivered by the Maestro Rechargeable System for the Treatment of Obesity | Biotech Hunter

Enrollment

239

Participants

Timeline

Start Date

May 31, 2011

Primary Completion Date

February 28, 2013

Study Completion Date

January 31, 2021

Conditions

Obesity

Interventions

DEVICE

vBloc (Active Device)

Active device will deliver vBloc Therapy

DEVICE

Sham (Non-active Device)

Functional non-active control device will deliver no vBloc Therapy

Trial Locations (10)

Virginia Commonwealth University, Richmond

University of Minnesota, Minneapolis

Mayo Clinic Rochester, Rochester

HonorHealth (formerly Scottsdale Healthcare Bariatric Center), Scottsdale

Scripps Clinic Nutrition & Metabolic Research Center, La Jolla

Stanford University, Stanford

Oregon Health & Science University, Portland

Tufts Medical Center, Boston

Institute of Weight Control, Baulkham Hills

Adelaide Bariatric Centre, Bedford Park, SA